Philip Arlen | President And Chief Executive Officer
Precision Biologics Inc

Founder and CEO of Precision Biologics (2012), board-certified medical oncologist, on clinical staff at the National Cancer Institute (NCI) and Walter Reed Medical Center, Co-Chair for the National Institutes of Health (NIH) Institutional Review Board (IRB). Medical degree (MD) 1991, Medical College of Georgia, USA
Fellowship at Emory University, USA, in Hematology/Oncology 1994-1997.  National Cancer Institute, USA, most recently as the Director of the Clinical Research Group for the Laboratory of Tumor Immunology and Oncology.  Involved in development of a programmatic approach to vaccine clinical trials conducted at the NCI as well as at numerous other leading cancer centers throughout the U.S. Principal Investigator and/or Associate Investigator on numerous clinical trials involving the use of cancer vaccines and other immunostimulatory molecules.
Authored or coauthored over 100 peer reviewed manuscripts in internationally known scientific and medical journals, including: Journal of Clinical Oncology, Clinical Cancer Research, Cancer Immunology and Immunotherapy. Received the NIH Award of Merit for major contributions to the field of cancer immunotherapy in 2003. In 2022, received the NIH Directors Award for achieving national recognition and prominence in human research protections as evidenced by accreditation from the Association for the Accreditation of Human Research Protection Programs.